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Differential control of gene expression has become a cen- 
tral theme in modern molecular biology. The lipophilic hor- 
mones, because they are able both to diffuse from asource 
and permeate to a target, are ideal candidates to serve 
as regulators of this process. These hormones, including 
the steroids, retinoids, thyroid hormones, and vitamin DS, 
are potent regulators of development, cell differentiation, 
and organ physiology (Figure 1). Historically, they were 
isolated in the early part of this century based on their 
abilities to affect development, differentiation, metamor- 
phosis, and physiology. In addition, many of these hor- 
mones were associated with known human diseases, and 
by the middle of the century glucocorticoids had gained 
popularity as a therapeutic agent. While the mediators of 
the action of these hormones remained elusive, develop- 
ment of radiolabeled ligands allowed the identification of 
‘Correspondence should be addressed to this author. 
Overview 
binding proteins that were shown to translocate from the 
cytoplasm to the nucleus, leading to a suggested link be- 
tween transcriptional control and physiology (Jensen et 
al., 1966). This concept was elaborated upon by the work 
of Ashburner et al. (1974), which demonstrated that ecdy- 
steroids, the metamorphic hormones of insects, trigger 
chromosomal puffing at specific sites in the Drosophila 
polytene chromosome. In the mid-1970s, steroids were 
shown to be targeted to their responsive tissues by the 
presence of specific high affinity receptor proteins. Unlike 
the water-soluble peptide hormones and growth factors, 
which bind to cell surface receptors, the fat-soluble steroid 
hormones can pass through the lipid bilayer of the cell 
membrane and interact with their cognate receptors. The 
subsequent identification of hormonally responsive target 
genes within these tissues completed the initial character- 
ization of a steroid hormone signaling pathway. Together, 
these biochemical studies (reviewed by Yamamoto, 1985) 
provided t,ie classic model of steroid hormone action. In 
this model it was postulated that the binding of hormone 
to its receptor induces an allosteric change that enables 
the hormone-receptor complex to bind to high affinity sites 
in chromatin and modulate transcription. The cloning of 
the steroid receptors was an essential prerequisite for ulti- 
mately understanding the molecular basis of this model. 
It has now been 10 years since the isolation of cDNAs 
encoding the glucocorticoid and estrogen receptors, 
which were the first cellular transcription factors for RNA 
polymerase II to be cloned (Hollenberg et al., 1985; Mies- 
feld et al., 1986; Green et al., 1986). The homology of these 
receptors to the v-erbA oncogene led to the discovery of 
the c-erbA locus as the thyroid hormone receptor (Sap et 
al., 1986; Weinberger et al., 1986). The cloning of these 
first receptors represented a critical advance and demon- 
strated that chemically distinct ligands interact with struc- 
turally related receptors. The discovery in 1987 of the re- 
ceptors for the vitamin A metabolite known as retinoic acid 
solidified the view of the existence of a nuclear receptor 
superfamily (GiguBre et al., 1987; Petkovich et al., 1987). 
Following this work came the identification of receptors 
for all known nuclear hormones as well as a myriad of 
orphan receptors and the emerging concept that novel 
hormonal ligands might exist. Also during this time, the 
first insect receptors were discovered (Nauber et al., 1988; 
Oro et al., 1988). The identification of the ecdysone recep- 
tor as a member of the nuclear receptor superfamily 
(Koelle et al., 1991) suggested the likely universal nature 
of these receptors in animals and clearly demonstrated 
that the receptors evolved prior to the divergence of verte- 
brates and invertebrates. The discovery of retinoid X re- 
ceptor (RXR) (Mangelsdorf et al., 1990) represented an- 
other important advance both in identifying the mediator 
of receptor heterodimerization and the novel orphan ligand 
9-cis retinoic acid. Together these findings led to our mod- 
ern view of hormonal signaling. 
The nuclear receptors are characterized by a central 
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Figure 1. Structures of the Known Ligands for Nuclear Hormone Receptors 
DNA-binding domain (DBD) (Figure 2) which targets the 
receptor to specific DNA sequences known as hormone 
response elements. The DBD is composed of two highly 
conserved zinc fingers that set the nuclear receptors apart 
from other DNA-binding proteins (Berg, 1989; Klug and 
Schwabe, 1995). The C-terminal half of the receptor en- 
compasses the ligand-binding domain (LBD), which pos- 
sesses the essential property of hormone recognition and 
ensures both specificity and selectivity of the physiologic 
response. In its simplest terms, the LBD can be thought 
of as a molecular switch that, upon binding ligand, shifts 
the receptor to a transcriptionally active state. It is un- 
known whether these domains evolved independently of 
3,5,3’-L-triodothyronine 
oeoH 
15-deoxy-A’*,t4-prostaglandin J, 
each other or whether the first members of the family were 
simply constitutive transcription factors. Nonetheless, the 
ancient association of an LBD with a DBD has proven to 
be a highly successful union. Indeed, the success of this 
family is reflected by the observation that evolution has 
selected nuclear receptors as the dominant mediator of 
organ physiology as well as the regulator of insect morpho- 
genesis. Because there are other intracellular receptor 
signaling pathways, such as sterol-regulatory element- 
binding protein for cholesterol (Wang et al., 1994) and the 
arylhydrocarbon receptor for dioxin (Burbach et al., 1992), 
the discovery of a single family of receptors for steroids, 
retinoids, and thyroid hormones was unexpected. Appar- 
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Figure 2. Nuclear Receptors Share Common 
Structure/Function Domains 
A typical nuclear receptor contains a variable 
N-terminal region (A/B), a conserved DBD (C), 
a variable hinge region (D), a conserved LBD 
(E), and a variable C-terminal region (F). Nu- 
clear receptors can be grouped into four 
classes according to their ligand binding, DNA 
binding, and dimerization properties: steroid 
receptors, RXR heterodimers, homodimeric or- 
phan receptors, and monomeric orphan recep- 
tors. Shown are representative receptors for 
each group. A complete listing is given in Fig- 
ure 3. Question marks refer to orphan recep- 
tors for which ligands are not known. See ac- 
companying reviews for details. 
NAME (#GENES) SPECIES 
CeF16H9.1 
HORMONE 
CORTISONE 
ALDOSTERONE 
PROGESTERONE 
TESTOSTERONE 
ECDYSONE 
(FARNESOIDS) 
VITAMIN D3 
THYROID HORMONE 
9-cRA, TERPENOIDS 
(EICOSANOIDS) 
RETINOIC ACID 
HALF-SITE 
AGAACA 
AGAACA 
AGAACA 
AGAACA 
RGKTCA 
AGGTCA 
RGKTCA 
RGKTCA 
RGKTCA 
RGKTCA 
RGGTCA 
RGGTCA 
AGGTCA 
AGGTCA 
AGGTCA 
AAGTCA 
TCAAGGTCA 
AGGTCA 
AGTTCA 
WAWNAGGTCA 
WAWNAGGTCA 
CONFIGURATION 
m-3 
n-3 
IR-3 
IR-3 
IR-1 
I&l,DR-5 
DR.4 
DR-3 
DR-4 
DR.5 
IR-0, DR-4, ER-6,s 
DRS. IRS 
DR.1 
DA-1 
DR.1 
NR 
DH-0 
DR.1 
IR-0, DR-2,5, ER-8 
WWCWRGGTCA NH 
1NAWNAGGTCA NR 
RAAGGTCA NR. DR.5. IR-0 
YCAAGGYCR hl? 
TCAGGTCA NR 
ESTROGEN RGGTCA I R-3 
TTAGTTCA NR 
Figure 3. Known Members of the Nuclear Receptor Superfamily 
The dendrogram represents the relationship among known nuclear hormone receptors prepared from a multiple sequence alignment (Feng and 
Doolittle, 1967); it is not an evolutionary tree. Amino acid sequences from the entire DBD (including 16 flanking C-terminal residues) were aligned 
using the University of Wisconsin Genetics Computer Group program PILEUP. Receptors classified according to the scheme in Figure 2 are 
highlighted here in color: steroid receptors in red, RXR heterodimers in blue, homodimeric orphan receptors in green, and monomeric orphan 
receptors in brown. Receptors for which a classification scheme is lacking are colored black. Gene designations in parenthesis, e.g., RXR (6, E), 
indicate that these subtypes do not bind hormone. Species designations refer towhether the receptor has been identified in invertebrates, vertebrates, 
or both. Hormone activators given in parenthesis have not yet been proven to bind receptor. Hormone response elements are configured as direct 
repeats (DR), inverted repeats (IR), everted repeats (ER), or nonrepeats (NR) and are spaced by the given number of nucleotides. A maximum 
of two GenBank accession numbers (listed below) were allowed for each receptor type and species; we apologize to authors whose accession 
numbers could not be cited owing to this space limitation. 
For accession numbers and receptor types, species designations are as follows: f, zebrafish or other fish; a, Xenopus or other amphibian; c, 
chick or other avian; m, mouse; r, rat; h, human. 
Vertebrate receptors are GR (X72211, a; X04435, m; M14053, r; X03225, h); MR (U15135 and U15133, a; M36074, r; Ml6801, h); AR (X56955, 
a; L25901, c; X53779 and X59592, m; M20133, r; M20132 and M21748, h); PR (M37518, c; M68915, m; L16922, r; M1.5716, h); ER (M31559 and 
D28954, f; L20736, a; X03805, c; M38651, m; X61098, r; X03635 and Ml 1457, h); RARa (LO3398 and L03399, f; L11445 and 553907, a; M60909, 
m; S77802, r; X06614 and X06538, h); RAR6 (X59473 and X57340, c; X57628 and M60909, m; YOO291 and X07282, h); RARy (S74156 and 
LO3400, f; Ll1444 and X59396, a; X73973, c; Xl5848 and M34475, m; S77804, r; M24657 and M57707, h); TRo (D16461 and Dl6462, f; M35343 
and M35344, a; YO0987, c; X51983 and X07750, m; Ml8028 and M31174, r; M24746 and M24899, h); TR6 (D45245, f; M35359 and M35361, a; 
M65207 and X17504, c; 562756, m; JO3819 and J03933, r; M26747, h); VDR (U12641, c; D31969, m; JO4147, r; J03258, h); PPARc (M84161, 
a; X57638, m; M88592, r; LO2932 and S74349, h); PPAR6/6 (M84162, a; U10375 and L28116, m; U10375, h); PPARy (M84163, a; U10374 and 
UO9138, m; L40904, h); LXRa (U11685, r; U22662, h); LXR6 (UO9419, m; U14533 and U20389, r; U14534 and UO7132, h); MB67 (230425 and 
L29623, h); FXR (U09416 and U09418, m; U18374, r); xONR (X75163, a); NGFI-Ba (X70700, a; JO4113 and X60132, m; U17254, r; Ll3740 and 
D49728, h); NGFI-B8 (S53744, m; LO8595, r; X75918 and S77154, h); NGFI-By (D38530, r; U12767, h); RDRu (U22437, m; Ll4611 and U04897, 
h); ROR6 (L14160, r; T26966, h); RORy (H33887, r; U16997, h); REV-ERBa (X86010, m; M25804, r; M24696 and X72631, h); REV-ERB6 (Ut2142 
and UO9504, m; U20796 and X82777, r; L31785, h); RXRa (U29940, f; L11446, a; ME4817 and X66223, m; L06462, r; X52773, h); RXR8 (S73269, 
a; X66224 and D21831, m; M81766, r; M64620 and X63522, h); RXRy (U29694, f; Lll443, a; X58997, c; X66225 and M84619, m; S77608, r); 
RXRG (U29941, f); RXRE (U29942, 9; COUPa (X70299 and X70300, f; X63092, a; U07625 and X74134, m; U10995, r; X12795 and X16155, h); 
COUP8 (L25674 and X76654, m; X12794, h); COUPv (UO0697, c; X76653, m; M64497 and M62760, h); TR2c (M29960, h); TR28 (L27513, r; 
L27566 and U10990, h); TLX (S72373, c; 577482, m); HNF4 (D29015, m; X57133, r; X76930, h); ERRc (X51416, h); ERR6 (X51417, h); GCNF 
(U14666 and U09563, m); Ftz-Fla (S65876, m; D42152, r; U32592, h); Ftz-Flp (UO5001 and UO5002, a; M61365, m). 
Drosophila receptors are ECR (M74078); USP (X53417); SVP (M28863); XR78E/F (U31517); E78 (UOl807); TLL (M34639); E75A (X51548); DHR36 
(X89246); FTZ-Flu (M63711); FTZ-Fl6 (L06423); dHNF4 (PIR accession number 536218); DHR3 (M90806); Kntrps (X13331); KNRL (X14153); 
EGON (X16631). 
C. elegans receptors are CeFll Cl .6 (254270); CeC2B4.2 (250004); Ce21 D12.4 (U23518); Ce2H1.6 (247075); CeFllAl.3 (250857); CeZK418.1 
(UOO047); CeKOGAI .4 (U23449); CeF21 D12.4 (U23518); CeF16H9.1 (Z50005); CNR-14 (P41830); CHR-3 (P41626); CNR8 (P41829); CeF43Cl.4 
(009565); CeODR7 (P41933); CeB0280.8 (P41999). 
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ently the evolutionary drive for a single receptor family 
came from the suitability of the receptors to control physiol- 
ogy rather than the chemistry of the regulators. 
By 1990 a total of 15 members of the superfamily had 
been identified as receptors for all the known fat-soluble 
hormones. Today, there are more than 150 different mem- 
bers of the family, spanning a large diversity of animal 
species from worm to insect to human. While the availabil- 
ity of purified hormones and antibodies enabled the dis- 
covery of the first receptors, low stringency hybridization 
screening and genetic and molecular cloning techniques 
have allowed the identification of numerous members of 
the family for which there are no apparent ligands. These 
so-called orphan receptors are found in every metazoan 
species, and it can be expected that some may interact 
with novel ligands, while others may represent constitutive 
activators/repressors or factors whose activity is modu- 
lated by posttranslational modification. 
Figures 2 and 3 are diagrammatic representations of 
the structure/function and sequence relationships among 
the members of the nuclear hormone receptor superfam- 
ily. We use the term superfamily to encompass all of the 
known nuclear hormone receptors. The superfamily is of- 
ten further divided into the steroid receptor family and the 
thyroidlretinoidlvitamin D (or nonsteroid) receptor family. 
Each type of receptor constitutes a subfamily (e.g., the 
retinoic acid receptor [RAR] subfamily). Receptor sub- 
types are the products of individual genes (e.g., RARa, 
RARb, RAR$, and receptor isoforms are the products of 
alternate splicing, promoter usage, or both (e.g., RARal, 
RARa2). 
The nuclear receptorsuperfamilycan be broadly divided 
into four classes based on their dimerization and DNA- 
binding properties (Figure 2; see also Stunnenberg, 1993). 
Class I receptors include the known steroid hormone re- 
ceptors, which function as ligand induced homodimers 
and bind to DNA half-sites organized as inverted repeats. 
Class II receptors heterodimerize with RXR and character- 
istically bind to direct repeats (although some bind to 
symmetrical repeats as well). Exclusive of the steroid hor- 
mones, this group includes all other known ligand- 
dependent receptors. Class Ill receptors bind primarily to 
direct repeats as homodimers. Class IV receptors typically 
bind to extended core sites as monomers. Most of the 
orphan receptors fall into class Ill and IV categories. 
The dendrogram in Figure 3 summarizes the similarity 
among the receptors by sequence. It was constructed by 
selecting a single member of each receptor subfamily as 
representative and then producing a multiple sequence 
alignment based on their DBD sequences (for an alterna- 
tive evolutionary comparison of the receptors, see Gro- 
nemeyer and Laudet, 1995). Several themes emerge from 
a consideration of Figure 3. For example, when the differ- 
ent functional classes of receptors described in Figure 2 
are highlighted in color in Figure 3, a clear relationship 
between receptor function and sequence can be seen. 
Interestingly, most class II receptors (shown in blue in Fig- 
ure 3) are ligand dependent, and it seems likely that the 
remaining members of this family may also have ligands. 
Another potentially significant point is the great diversity 
in the rapidly expanding list of Caenorhabditis elegans 
receptors (shown in black in Figure 3). Although little is 
known about these receptors, one might speculate that 
some of these new receptor subtypes will be represented 
in vertebrates and that the nuclear receptor superfamily 
will continue its explosive growth in the future. 
The purpose of the ensuing reviews will be systemati- 
cally to discuss the major discoveries as well as the emerg- 
ing concepts that have come from the last 10 years of 
study on the members of this superfamily. Beato et al. 
review the steroid hormone receptor family, which, al- 
though they are taken as the archetype for this superfam- 
ily, are in fact a specialized branch that has only recently 
evolved in vertebrates. The review by Mangelsdorf and 
Evans focuses on the RXR heterodimers and orphan re- 
ceptors, both from a structural and mechanistic point of 
view. Kastner et al. review the recent efforts to character- 
ize receptor function genetically via homologous recombi- 
nation, which supports many earlier studies on hormone 
deficiency syndromes as well as revealing many unantici- 
pated developmental and physiologic effects. Finally, 
Thummel reviews advances in nonvertebrate Drosophila 
receptors, which establish a clear unity between the verte- 
brates and invertebrates and point out common genetic 
and mechanistic features underlying animal development 
and physiology. We have come to realize in the reviewing 
process that the progress of the field is so great that it is 
not possible to review any one area in exhaustive detail. 
The readers will be referred to many other excellent re- 
views that deal with portions of these subjects in more 
detail. Rather, the goal of this series is to present an over- 
view of the progress of the last 10 years and to chart the 
course for future research. Finally, we hope this series of 
reviews provides a realization that we are in the midst of 
an explosion in our understanding of hormonal signaling 
and that the next 10 years is likely to be as exciting and 
dramatic as the first. 
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